Snowball logo
logo
GSK_logo

GlaxoSmithKline plc

GSK β€’ NYSE
$51.65-$0.42Β  (0.81%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
33,422.735,48438,614.739,264.232,66741,353
COGS
11,047.511,56110,905.311,322.79,01711,178.3
Gross Profit
22,375.223,92327,709.427,941.423,65030,174.7
Operating Expenses & Income
Operating Income
5,896.67,784.48,5885,031.98,3388,663.2
Total Operating Expenses
16,478.516,138.719,121.522,909.515,31221,511.5
R&D Expenses
6,792.56,640.97,923.48,010.37,52511,455.7
Selling General & Admin Expenses
9,568.310,130.711,949.313,784.39,08811,372.6
Earnings from Continuing Operations
Interest Expense
(1,061)(1,035.2)(986.8)(822.9)(687)(860.8)
Interest Income
978.591.9761.1275.08531291
Income Tax Expense
112.3855.5962.6658.21,112782
Net Income
Net Income
5,934.518,097.86,274.53,222.45,7166,217
Supplemental
EBIT
5,904.77,809.88,6445,1528,0888,418.3
EBITDA
8,776.610,407.811,564.88,344.410,40213,842.8
In millions of USD, except % and values per 1 share